FDA.report

Application 091452

Type
ANDA
Sponsor
GLENMARK GENERICS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001MARLISSAETHINYL ESTRADIOL; LEVONORGESTRELTABLET;ORAL-280.03MG;0.15MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-1392MARLISSALevonorgestrel and Ethinyl EstradiolA-S Medication SolutionsANDACurrent
50090-1392MARLISSALevonorgestrel and Ethinyl EstradiolA-S Medication SolutionsANDACurrent
68462-388MARLISSALevonorgestrel and Ethinyl EstradiolGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-388MARLISSALevonorgestrel and Ethinyl EstradiolGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-388MARLISSALevonorgestrel and Ethinyl EstradiolGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-388MARLISSALevonorgestrel and Ethinyl EstradiolGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-388MARLISSALevonorgestrel and Ethinyl EstradiolGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-388MARLISSALevonorgestrel and Ethinyl EstradiolGlenmark Pharmaceuticals Inc., USAANDACurrent
68788-6339MARLISSALevonorgestrel and Ethinyl EstradiolPreferreed Pharmaceuticals Inc.ANDACurrent
68788-6339MARLISSALevonorgestrel and Ethinyl EstradiolPreferreed Pharmaceuticals Inc.ANDACurrent
68788-6339MARLISSALevonorgestrel and Ethinyl EstradiolPreferreed Pharmaceuticals Inc.ANDACurrent